163

Заключение

Можно сказать, что здравоохранение экономически развитых стран только начинает нарабатывать подходы к лечению ожирения, отвечающие современным представлениям о природе этого заболевания. Первые шаги, сделанные в этом направлении, обнадеживают. Однако, мы в самом начале пути. Видимо, будущее за программами, направленными на профилактику ожирения в обществе, за серьезными алгоритмами диагностики и лечения этого заболевания, за новыми, патогенетически обоснованными методами лечения. Необходимо уже сейчас осознать всю важность предстоящей работы. Решение проблемы ожирения - это увеличение качества и продолжительности жизни, снижение заболеваемости и смертности, экономия огромных средств, которые сейчас тратит общество в связи с ожирением и его осложнениями.

164

Приложения

Таблица 1

Максимально допустимая масса тела (по данным М. Н. Егорова и Л. М. Левитского, 1964 г.)

Рост	20 - 29 лет		30 - 39 лет		40 - 49 лет		50 - 59 лет		60 - 69 лет
См
	муж	жен	муж	жен	муж	жен	муж	жен	муж	жен
148	50,8	48,4	55,0	52,3	56,6	54,7	56,0	53,2	53,9	52,2
150	51,3	48,9	56,7	53,9	58,1	56,5	58,0	55,7	57,3	54,8
152	51,3	51,0	58,7	55,0	61,5	59,5	61,1	57,6	60,3	55,9
154	55,3	53,0	61,6	59,1	64,5	62,4	63,8	60,2	61,9	59,0
156	58,5	55,8	64,4	61,5	67,3	66,0	65,8	62,4	63,7	60,9
158	61,2	58,1	67,3	64,1	70,4	67,9	68,0	64,5	67,0	62,4
160	62,9	59,8	69,2	65,8	72,3	69,9	69,7	65,8	68,2	64,6
162	64,6	61,6	71,0	68,5	74,4	72,2	72,7	68,7	69,1	66,5
164	67,3	63,6	73,9	70,8	77,2	74,0	75,6	72,0	72,2	70,0
166	68,8	65,2	74,5	71,8	78,0	76,5	76,3	73,8	74,3	71,5
168	70,8	68,5	76,3	73,7	79,6	78,2	77,9	74,8	76,0	73,3
170	72,7	69,2	77,7	75,8	81,0	79,8	79,6	76,8	76,9	75,0
172	74,1	72,8	79,3	77,0	82,8	81,7	81,1	77,7	78,3	76,3
174	77,5	74,3	80,8	79,0	84,4	83,7	83,0	79,4	79,3	78,0
176	80,8	76,8	83,3	79,9	86,0	84,6	84,1	80,5	81,9	79,1
178	83,0	78,2	85,6	82,4	88,0	86,1	86,5	82,4	82,8	80,9
180	85,1	80,9	88,0	83,9	89,9	88,1	87,5	84,1	84,4	81,6
182	87,2	83,3	90,6	87,7	91,4	89,3	89,5	86,5	85,4	82,9
184	89,1	85,5	92,0	89,4	92,9	90,9	91,6	87,4	88,0	85,8
186	93,1	89,2	95,0	91,0	96,6	92,9	92,8	89,6	89,0	87,3
188	95,8	91,8	97,0	94,4	98,0	95,8	95,0	91,5	91,5	88,8
190	97,1	92,3	99,5	95,6	100,7	97,4	99,4	95,6	94,8	92,9

165

						Таблица 2
	Идеальная масса тела (по данным Metropolitan Life Insuranse Co)
Рост		Мужчины			Женщины
См
	Астеники	Нормосте-	Гиперстени-	Астеники	Нормостени-	Гиперсте-
		ники	ки		ки	ники
148				42,0 - 44,8	43,8 - 48,9	47,4 - 54,3
150				42,7 - 45,9	44,5 - 50,0	48,2 - 55,4
152				43,4 - 47,0	45,6 - 51,0	49,2 - 56,5
154				44,4 - 48,0	46,7 - 52,1	50,3 - 57,6
156				45,4 - 49,1	47,7 - 53,2	51,3 - 58,6
158	51,1 - 54,7	53,8 - 58,9	57,4 - 64,2	46,5 - 50,2	48,8 - 54,3	52,4 - 59,7
160	52,2 - 55,8	54,9 - 60,3	58,5 - 65,3	47,6 - 51,3	49,9 - 55,3	53,5 - 60,8
162	53,2 - 56,9	55,9 - 61,9	59,6 - 66,7	48,7 - 52,3	51,0 - 56,8	54,6 - 62,2
164	54,3 - 57,9	57,0 - 62,5	60,7 - 68,8	49,8 - 53,4	52,0 - 58,2	55,9 - 63,7
166	55,4 - 59,2	58,1 - 63,7	61,7 - 69,6	50,8 - 54,6	53,3 - 59,8	57,3 - 65,1
168	56,5 - 60,6	59,2 - 65,1	62,9 - 71,1	52,0 - 56,0	54,7 - 61,5	58,8 - 66,5
170	57,9 - 62,0	60,7 - 66,7	64,3 - 72,9	53,4 - 57,9	56,1 - 62,9	60,2 - 67,9
172	59,4 - 63,4	62,1 - 68,3	66,0 - 74,7	54,8 - 58,9	57,5 - 64,3	61,6 - 69,3
174	60,8 - 64,9	63,5 - 69,9	67,6 - 76,2	56,3 - 60,3	59,0 - 65,8	61,3 - 70,8
176	62,6 - 66,4	64,9 - 71,3	69,0 - 77,6	57,7 - 61,9	60,4 - 67,2	64,5 - 72,3
178	63,6 - 68,2	66,5 - 72,8	70,4 - 79,1	59,1 - 63,6	61,8 - 68,6	65,9 - 74,1
180	65,1 - 69,6	67,8 - 74,7	71,9 - 80,9	60,5 - 65,1	63,3 - 70,1	67,3 - 75,9
182	66,5 - 71,0	69,2 - 76,3	73,6 - 82,7	62,0 - 66,5	64,7 - 71,5	68,8 - 77,7
184	67,9 - 72,5	70,7 - 78,1	75,2 - 84,5	63,4 - 67,9	66,1 - 72,7	70,2 - 79,5
186	69,4 - 74,0	72,1 - 79,0	76,7 - 86,2
188	70,8 - 75,8	73,5 - 81,7	78,5 - 88,0
190	72,2 - 77,2	75,3 - 83,5	80,3 - 89,8
192	73,6 - 78,6	77,1 - 85,3	81,8 - 91,6
194	75,1 - 80,1	78,9 - 87,0	83,2 - 93,4

166

Рекомендуемая литература

1.Беюл Е. А., Оленева В. А., Шатерников В. А. Ожирение. М. Медицина, 1985. - 190 с.

2.Вознесенская Т.Г. Нейроэндокринные синдромы. В кн.: Вегетативные расстройства: Клиника, лечение, диагностика./ Под ред. А.М. Вейна. – М.: Медицинское информационное агенство, 1998. – с. 439-442.

3.Гинзбург М. М. Козупица Г. С. Ожирение. Дисбаланс энергии или дисбаланс нутриентов?//Проблемы эндокринологии 1997, Т.43, №5. - С. 42-46.

4.Гинзбург М. М. Козупица Г. С. Синдром инсулинрезистентности // Проблемы эндокринологии. - 1997, т.43, №1. - С. 40-43.

5.Гинзбург М. М., Козупица Г. С. Изолипан (дексфенфлюрамин) и его место в лечении ожирения//Проблемы эндокринологии. - 1996., т. 42, №3. - С. 38-39.

6.Гинзбург М. М., Козупица Г. С., Сергеев О. В. Связь инсулина и артериального давления при ожирении у женщин//Проблемы эндокринологии. - 1996,

Т. 42, № 4. - С. 25-27.

7.Гинзбург М. М., Козупица Г.С., Значение распределения жира при ожирении// Проблемы эндокринологии. – 1996.- Т.42, №6.- С. 30-34.

8.Гинзбург М. М., Сергеев О. В., Козупица Г. С. Зависимость артериального давления от распределения жира у женщин, больных ожирением//Проблемы эндокринологии. - 1997, т. 43, №1. - С. 31-33.

9.Гинзбург М.М., Козупица Г.С., Крюков Н.Н. Ожирение и метаболический

синдром. Влияние на состояние здоровья, профилактика и лечение. - Самара:

изд-во «Парус», 2000.- 159 с.

10.Денисов И.Н., Улумбеков Э.Г. 2000 болезней от А до Я.- ГЭОТАР МЕДИ-

ЦИНА. 1999.

11.Джанашия П.Х., Диденко В.А. Оценка состояния инсулинового обмена у больных артериальной гипертонией, как метод ранней диагностики сопутствующего метаболического Х-синдрома. // Российский кардиологический журнал. - 1999, №5.-С.25-32.

12.Егоров М. Н., Левитский Л. М. Ожирение. М. «Медицина» 1964, 306 с. 13.Зимин Ю.В. Артериальная гипертония при сахарном диабете: особенности

патогенеза и лечения (обзор). // Терапевтический архив. - 1998, №10. - С.1520.

14.Карпман В. Л., Белоцерковский З. Б., Гудков И. А. Тестирование в спортивной медицине. - М.: Физкультура и спорт, 1988. - 208 с.

15.Кендыш И. Н. Регуляция углеводного обмена М. «Медицина», 1985. – 272 с.

167

16.Кобалава Ж.Д. Артериальная гипертония и ожирение: случайная ассоциация или причинно-следственная связь? //Клиническая фармакология и терапия

2000.-Т. 9, № 3.-С.35-39.

17.Козупица Г.С., Зотанина Т.В., Гинзбург М.М. Динамика состава тела как мера адаптации организма к физическим нагрузкам//Материалы VIII международного симпозиума «Эколого-физиологические проблемы адаптации».- М., 1998.- С.186-187.

18.Крутикова Е. В., Преображенский Д. В. Влияние антигипертензивных препаратов на углеводный обмен//Кардиология, 1995. - Т.35, №11. – С. 58-64.

19.Крюков Н. Н., Волобуев А. Н., Романчук П. И. Изменение функции локальных гемодинамических регуляторных систем в генезе изолированной систолической гипертонии. Кардиология 1998, №7 С. 76-78.

20.Крюков Н.Н., Качковский М. А. Комбинированные антигипертензионные препараты: преимущества и недостатки// Кардиология.- 1999, №2.- С. 92-96.

21.Оганов Р.Г., Перова Н.В., Мамедов М.Н., Метельская В.А. Сочетание компонентов метаболического синдрома у лиц с артериальной гипертонией и их связь с дислипидемией//Терапевтический архив.-1998, №12.-С.19-24.

22.Панков Ю. А. Лептин - пептидный гормон адипоцитов//Биоорганич. Химия.

– 1996, Т. 22 (3). - С. 228-233.

23.Перова Н.В., Метельская В.А., Оганов Р.Г. Метаболический синдром: патогенетические взаимосвязи и направления коррекции// Кардиология. – 2001,

№3.-С.44-49.

24. Справочник по диетологии. Под ред. М. А. Самсонова и А. А. Покровского. М. “Медицина” 1992., 464 с.

25.Смолянский Б.Л., Абрамова Ж.И. Справочник по лечебному питанию. СПБ

«Гиппократ», 1993. – 303 с.

26.Татонь Ян. Ожирение. Патофизиология, диагностика, лечение. –Варшава: Польское медицинское издательство, 1988. - 363 с.

27.Терещенко И.В. Эндокринные расстройства у юношей и девушек в пубертатном периоде. // Медицина и здравоохранение. Обзорная информация.

Москва, 1991 - 66 с.

28.Хадипаш Л.А.; Перова Н.В.; Мамедов М.Н.; Олферьев А.М. и др. Кластеры компонентов метаболического синдрома у больных сахарным диабетом типа

2// Проблемы эндокринологии.-2001.-Т.-47,№ 47.-С.30-34.

29.Химический состав пищевых продуктов / Справочные таблицы содержания основных пищевых веществ и энергетической ценности блюд и кулинарных изделий. Под ред. И.М. Скурихина и В.А. Шатерникова. М.: “Легкая и пищевая промышленность”, 1984. – 254 с.

30.Шурыгин Д. Я., Вязицкий П. О., Сидоров К. А. Ожирение. – Ленинград: “Медицина”, 1980. - 262 с.

168

31.Acheson K. J., Schutz Y., Bessard T. et al., Glycogen storage capacity and de novo lipogenesis during massive carbohydrate overfeeding in man. Am. J. Clin. Nutr. 1988, Vol.48. - P. 240-247.

32.Ackroff K; Sclafani A. Effects of the lipase inhibitor orlistat on intake and preference for dietary fat in rats. Am J Physiol 1996 Jul;271(1 Pt 2):R48-54.

33.Albu JB, Curi M, Shur M, Murphy L, Matthews DE, Pi-Sunyer FX Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity. Am J Physiol 1999 Sep;277(3 Pt 1):E551-60

34.Allison DB; Faith MS Hypnosis as an adjunct to cognitive-behavioral psychotherapy for obesity: a meta-analytic reappraisal. J Consult Clin Psychol 1996 Jun;64(3):513-6

35.Amine EK; Samy M Obesity among female university students in the United Arab Emirates. J R Soc Health 1996 Apr;116(2):91-6

36.Andersson I., Rossner S .The Gustaf study: repeated, telephone-administered 24hour dietary recalls of obese and normal-weight men--energy and macronutrient intake and distribution over the days of the week// J Am Diet Assoc .- 1996, № Jul;96(7).-P.686-778.

37.Ard JD, Rosati R, Oddone EZ Culturally-sensitive weight loss program produces significant reduction in weight, blood pressure, and cholesterol in eight weeks. J Natl Med Assoc 2000 Nov;92(11):515-23

38.Ardizzi A; Grugni G; Moro D; Guazzaloni G; Toselli E; Morabito F GutierrezFisac JL; Regidor E; Rodriguez C Trends in obesity differences by educational level in Spain. J Clin Epidemiol 1996 Mar;49(3):351-4

39.Astrup A Dietary approaches to reducing body weight. Baillieres Best Pract Res Clin Endocrinol Metab 1999 Apr;13(1):109-20

40.Astrup A Macronutrient balances and obesity: the role of diet and physical activity. Public Health Nutr 1999 Sep;2(3A):341-7

41.Astrup A The American paradox: the role of energy-dense fat-reduced food in the increasing prevalence of obesity. Curr Opin Clin Nutr Metab Care 1998 Nov;1(6):573-7

42.Astrup A, Ryan L, Grunwald GK, Storgaard M, Saris W, Melanson E, Hill JO The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br J Nutr 2000 Mar;83 Suppl 1:S25-32

43.Astrup A., Andersen T., Henriksen O., et al., Impaired glucose-indused thermogenesis in skeletal muscle in obesity. Int. J. Obes/ 1987 11 51-66.

44.Astrup A., Buemann B., Western P., et al., Obesity as an adaptation to a high fat diet: evidence from a cross-sectional study. Am. J. Clin. Nutr. 1994, Vol.59. - P. 350-355.

45.Attwood CR Low-fat diets for children: practicality and safety. Am J Cardiol 1998 Nov 26;82(10B):77T-79T

169

46.Balle J; Almdal TP TT Behandling af adipositas i patientgrupper. Ugeskr Laeger 1996 Aug 5;158(32):4509-12

47.Ballor D. L., Poehlman E. T. Exercise-training enhances fat-free mass preservation during diet-induced weight loss: a meta-analytical finding. Int J Obes Relat Metab Disord 1994 18 35-40.

48.Bandini LG, Vu D, Must A, Cyr H, Goldberg A, Dietz WH Comparison of highcalorie, low-nutrient-dense food consumption among obese and non-obese adolescents. Obes Res 1999 Sep;7(5):438-43

49.Birketvedt GS, Florholmen J, Sundsfjord J, Osterud B, Dinges D, Bilker W, Stunkard A Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA 1999 Aug 18;282(7):657-63

50.Bjorntorp P Evolution of the understanding of the role of exercise in obesity and its complications. Int J Obes Relat Metab Disord 1995 Oct;19 Suppl 4:S1-4

51.Bolton-Smith C., Woodward M. Dietary composition and fat to sugar rations in relation to obesity. Int. J. Obes. 1994 18 820-828.

52.Bray G. A. Obesity: a time bomb to be defused Lancet 1998 352 18 p160-161 53.Bray GA, Popkin BM Dietary fat intake does affect obesity! Am J Clin Nutr 1998

Dec;68(6):1157-73

54.Brunner L, Levens N The regulatory role of leptin in food intake. Curr Opin Clin Nutr Metab Care 1998 Nov;1(6):565-71

55.Bryner RW, Ullrich IH, Sauers J, Donley D, Hornsby G, Kolar M, Yeater R Effects of resistance vs. aerobic training combined with an 800 calorie liquid diet on lean body mass and resting metabolic rate. J Am Coll Nutr 1999 Apr;18(2):115-21 56.Bryson JM; King SE; Burns CM; Baur LA; Swaraj S; Caterson ID Changes in glucose and lipid metabolism following weight loss produced by a very low calo-

rie diet in obese subjects. Int J Obes Relat Metab Disord 1996 Apr;20(4):338-45 57.Buemann B, Toubro S, Astrup A Substrate oxidation and thyroid hormone re-

sponse to the introduction of a high fat diet in formerly obese women. Int J Obes Relat Metab Disord 1998 Sep;22(9):869-77

58.Burstein R; Epstein Y; Charuzi I; Suessholz A; Karnieli E; Shapiro Y Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation. Int J Obes Relat Metab Disord 1995 Aug;19(8):558-61

59.Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999 Oct 7;341(15):1097-105

60.Campbell D.B. Dexfenfluramine: an overview of its mechanisms of action. Rev. Contemp. Pharmacother. 1991. Vol. 2., N2. - P. 93-113

61.Campbell LV A change of paradigm: obesity is not due to either 'excess' energy intake or 'inadequate' energy expenditure. Int J Obes Relat Metab Disord 1998 Nov;22(11):1137

62.Campbell ML, Mathys ML.Pharmacologic options for the treatment of obesity// Am J Health Syst Pharm.- 2001.-V Jul 15;58, №14.-Р.1301-1308.

170

63.Campfield LA; Smith FJ; Mackie G; Tenenbaum R; Sassano ML; Mullin J; Kaiser K; Kierstead RW Insulin normalization as an approach to the pharmacological treatment of obesity. Obes Res 1995 Nov;3 Suppl 4:591S-603S

64.Carmichael A. R. Treatment for morbid obesity. Postgrad Med J 1999 Jan;75(879):7-12

65.Carmody TP, Brunner RL, St Jeor ST Hostility, dieting, and nutrition attitudes in overweight and weight-cycling men and women. Int J Eat Disord 1999 Jul;26(1):37-42

66.Caro JF; Kolaczynski JW; Nyce MR; Ohannesian JP; Opentanova I; Goldman WH; Lynn RB; Zhang PL; Sinha MK; Considine RV Decreased cerebrospinalfluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996 Jul 20;348(9021):159-61

67.Casanueva FF, Dieguez C Neuroendocrine regulation and actions of leptin. Front Neuroendocrinol 1999 Oct;20(4):317-63

68.Chen M Observation of curative effect of lipid lowering and fat restraining tablets on complicated obesity. J Tradit Chin Med 1995 Dec;15(4):252-5

69.Chitwood LF; Brown SP; Lundy MJ; Dupper MA Metabolic propensity toward obesity in black vs white females: responses during rest, exercise and recovery. Int J Obes Relat Metab Disord 1996 May;20(5):455-62

70.Chow WH; McLaughlin JK; Mandel JS; Wacholder S; Niwa S; Fraumeni JF Jr Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 1996 Jan;5(1):17-21

71.Cohn G; Valdes G; Capuzzi DM. Pathophysiology and treatment of the dyslipidemia of insulin resistance// Curr Cardiol Rep.- 2001.- V. Sep;3, №5.- Р.416-423.

72.Coli P; Pea E; Lacorte M; Passaglia C; Carrai M Valutazione (a breve termine) del comportamento degli indici antropometrici e dei parametri bioumorali in soggetti obesi trattati con acarbosio. Minerva Med 1996 Apr;87(4):161-70

73.Considine RV; Considine EL; Williams CJ; Hyde TM; Caro JF The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996 Jul;45(7):992-4

74.Corona Muniz I; Camacho Hernandez R; Escobedo de la Pena J Оbesidad, distribucion central de la grasa corporal y cardiopatia isquemica en poblacion mexicana. Arch Inst Cardiol Mex 1996 Mar-Apr;66(2):143-50

75.De Pue JD; Clark MM; Ruggiero L; Medeiros ML; Pera V Jr Maintenance of weight loss: a needs assessment. Obes Res 1995 May;3(3):241-8

76.DeFronzo R.A., Ferrannini E. Insulin resistance, a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dislipidemia and atherosclerotic cardiovascular disease. // Diabetes Care. - 1991. - V.4., N.3. - P. 173-194.

77.Desaive C A critical review of a personal series of 1000 gastroplasties. Int J Obes Relat Metab Disord 1995 Sep;19 Suppl 3:S56-60

171

78.Dick A, Suskin N Fitness, fatness, and mortality in men. Clin J Sport Med 1999 Jul;9(3):187

79.Doucet E, Imbeault P, Almeras N, Tremblay A Physical activity and low-fat diet: is it enough to maintain weight stability in the reduced-obese individual following weight loss by drug therapy and energy restriction? Obes Res 1999 Jul;7(4):32333

80.Drent ML; Larsson I; William-Olsson T et al., Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes Relat Metab Disord 1995 Apr;19(4):221-6

81.Drewnowski A., Krahn D. D., Demitrack M. A. et al., Naloxone, an opiate blocker, reduces the consumption of sweet high-fat food in obese and len female binge eaters. Am. J. Clin. Nutr. 1995 61 6 1206-1212.

82.Ewbank PP; Darga LL; Lucas CP Physical activity as a predictor of weight maintenance in previously obese subjects. Obes Res 1995 May;3(3):257-63

83.Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases// J Clin Endocrinol Metab.- 2001.-V. Aug;86, №8.-Р.3574-8.

84.Felber J. P. From obesity to diabetes. Pathophysiological considerations.// Int. J. Obes. - 1992. - V.16. - P. 937-952.

85.Flatt JP How NOT to approach the obesity problem. Obes Res 1997 Nov;5(6):632-3

86.Flatt J-P. Importance of nutrient balance in body weight regulation. Diabbetes. Metab. Rev. - 1988. - V.6. - P. 571-581

87.Flegal K. M. Caroll M. D., Kuczmarski R. J. Overweight and obesity in the US: prevalens and trends, 1960-1994. Int. J. Obes. 1998 22 39-47

88.Foreyt JP, Poston WS 2nd. The challenge of diet, exercise and lifestyle modification in the management of the obese diabetic patient. Int J Obes Relat Metab Disord 1999 Jun;23 Suppl 7:S5-11

89.Fox AA; Thompson JL; Butterfield GE; Gylfadottir U; Moynihan S; Spiller G Effects of diet and exercise on common cardiovascular disease risk factors in moderately obese older women. Am J Clin Nutr 1996 Feb;63(2):225-33

90.Frering V; Honnorat D; Riou JP; Partensky C Resultats a distance de la gastroplastie verticale calibree pour obesite morbide. Ann Chir 1996;50(2):139-45 91.Fricken J., Rozen R., Melchior J. S., et al., Energy-metabolism adaptation (n

obese adults on a very low calorie diet. Am. J. Clin. Nutr. 1991, 53 826-830 92.Gandolfo P; Gianetta E; Meneghelli A; Cuneo S; Scopinaro N; Adami GF Com-

portamento alimentare preoperatorio e calo ponderale dopo "gastric banding" per l'obesita. Minerva Gastroenterol Dietol 1996 Mar;42(1):7-10

93.Garrow JS; Summerbell CD Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects. Eur J Clin Nutr 1995 Jan;49(1):1-10

172

94.George V., Tremblay A., Despres J. P. et al., Evience for the existence of small eaters and large eaters of similar fat-free mass and activity level. Int. J. Obes. - 1989. - V.13., N1. - P. 43-53.

95.Gibney MJ Optimal macronutrient balance. Proc Nutr Soc 1999 May;58(2):421-5 96.Glaum SR; Hara M; Bindokas VP; Lee CC; Polonsky KS; Bell GI; Miller RJ Leptin, the obese gene product, rapidly modulates synaptic transmission in the hy-

pothalamus. Mol Pharmacol 1996 Aug;50(2):230-5

97.Goldstein DJ; Rampey AH Jr; Roback PJ; Wilson MG; Hamilton SH; Sayler ME; Tollefson GD Efficacy and safety of long-term fluoxetine treatment of obesity-- maximizing success. Obes Res 1995 Nov;3 Suppl 4:481S-490S

98.Granberry MC.; Fonseca VA. Insulin resistance syndrome: options for treatment// South Med J .-1999, №Jan;92(1).-P.2-15.

99.Greenlund KJ; Liu K; Dyer AR; Kiefe CI; Burke GL; Yunis C Body mass index in young adults: Associations with parental body size and education in the CARDIA Study. Am J Public Health 1996 Apr;86(4):480-5

100.Greeno CG, Wing RR, Marcus MD How many donuts is a "binge"? Women with BED eat more but do not have more restrictive standards than weightmatched non-BED women. Addict Behav 1999 Mar-Apr;24(2):299-303

101.Groop L, Orho-Melander M. The dysmetabolic syndrome// J Intern Med. – 2001.- V.Aug.250, №2.-Р.105-20.

102.Grundy SM The optimal ratio of fat-to-carbohydrate in the diet. Annu Rev Nutr 1999;19:325-41

103.Guezennec CY Reponses et adaptations hormonales lors d'efforts de courte

duree et sous l'effet de l'entrainement. Bull Acad Natl Med	1995
Oct;179(7):1449-57; discussion 1458-9

104.Guillaume M; Lapidus L; Beckers F; Lambert A; Bjorntorp P. Familial trends of obesity through three generations: the Belgian-Luxembourg child study. Int J Obes Relat Metab Disord 1995 Sep;19 Suppl 3:S5-9

105.Gutierrez-Fisac JL; Regidor E; Rodriguez C Trends in obesity differences by educational level in Spain. J Clin Epidemiol 1996 Mar;49(3):351-4

106.Guy-Grand B. The clinical uses of dexfenfluramine in the management of obesity. /Rev. Contemp. Pharmacother. 1991 2. 2. 115-128.

107.Hakala P, Rissanen A, Koskenvuo M, Kaprio J, Ronnemaa T Environmental factors in the development of obesity in identical twins. Int J Obes Relat Metab Disord 1999 Jul;23(7):746-53

108.Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Relat Metab Disord 1999 Oct;23(10):1016-24

109.Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. Thermogenic effects of sibutramine in humans. Am J Clin Nutr 1998 Dec;68(6):1180-6

110.Hardie LJ; Rayner DV; Holmes S; Trayhurn P Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not

173

Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun 1996 Jun 25;223(3):660-5

111.Hashimoto N., Saito Y. Diagnostic criteria of insulin resistance and multiple risk factor syndrome// Nippon Rinsho .-2000.- V.Feb;58, №2.- Р.405-415.

112.Hassink SG; Sheslow DV; de Lancey E; Opentanova I; Considine RV; Caro JF Serum leptin in children with obesity: relationship to gender and development. Pediatrics 1996 Aug;98(2 Pt 1):201-3

113.Helge JW, Fraser AM, Kriketos AD, Jenkins AB, Calvert GD, Ayre KJ, Storlien LH Interrelationships between muscle fibre type, substrate oxidation and body fat. Int J Obes Relat Metab Disord 1999 Sep;23(9):986-91

114.Hellerstein M. K., Christiansen M., Kaempfer S., et al., Measurement of de novo lipogenesis in humans using stable isotopes. J. Clin. Invest. 1991 87 18411852.

115.Hernandez B, Gortmaker SL, Colditz GA, Peterson KE, Laird NM, ParraCabrera S Association of obesity with physical activity, television programs and other forms of video viewing among children in Mexico city. Int J Obes Relat Metab Disord 1999 Aug;23(8):845-54

116.Hernandez B; Peterson K; Sobol A; Rivera J; Sepulveda J; Lezana MA Overweight in 12-49 year-old women and children under 5 years of age in Mexico, Salud Publica Mex 1996 May-Jun;38(3):178-88

117.Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999 Oct 27;282(16):1568-75

118.Hill JO, Peters JC Environmental contributions to the obesity epidemic. Science 1998 May 29;280(5368):1371-4

119.Himes CL Obesity, disease, and functional limitation in later life. Demography 2000 Feb;37(1):73-82

120.Hodge AM; Dowse GK; Gareeboo H; Tuomilehto J; Alberti KG; Zimmet PZ Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. Int J Obes Relat Metab Disord 1996 Feb;20(2):137-46

121.Hoie LH; Bruusgaard D Compliance, clinical effects, and factors predicting weight reduction during a very low calorie diet regime. Scand J Prim Health Care 1995 Mar;13(1):13-20

122.Holander P.A., Elbein S.C., Hirsch I.B. et al., Role of orlistat in the treatment of obese patients with type 2 diabetes./ Diabetes Care 1998 v21 №8 p1288-1294

123.	Holst JJ (Leptin--a new way to diet?) Ugeskr Laeger	1996 Aug
5;158(32):4505-8
124.	Horn-Ross P. L. Phytoestrogens, body composition, and breast cancer. Cancer
Causes Control 1995 Nov;6(6):567-73

174

125.Horton T. J., Drougas H., Brachey A., et al., Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am. J. Clin. Nutr. 1995 62 1 1929.

126.Howard BV Insulin resistance and lipid metabolism. Am J Cardiol 1999 Jul 8;84(1A):28J-32J

127.Husemann B. Therapie der extremen Fettsucht--Ist der Chirurg gefragt? Zentralbl Chir 1996;121(5):349-53

128.Husemann B; Reiners V Erste Ergebnisse nach vertikaler Gastroplastik zur Behandlung der extremen Adipositas. Zentralbl Chir 1996;121(5):370-5

129.Hvizdos KM, Markham A Orlistat: a review of its use in the management of obesity. Drugs 1999 Oct;58(4):743-60

130.Iizuka Y.; Gotoda T.; Ishibashi S.;, Yamada N. CD36 deficiency and insulin resistance// Lancet.- 2001.- V. Jul 21, №358(9277):243.- discussion 244.

131.Ikeda H; Odaka H AO-128, alpha-glucosidase inhibitor: antiobesity and antidiabetic actions in genetically obese-diabetic rats, Wistar fatty. Obes Res 1995 Nov;3 Suppl 4:617S-621S

132.Kopf D; Muhlen I; Kroning G; Sendzik I. et al. Insulin sensitivity and sodium excretion in normotensive offspring and hypertensive patients// Metabolism/- 2001.- V. Aug;50, №8.- Р.929-35.

133.Jensen LB, Kollerup G, Quaade F, Sorensen OH Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation. J Bone Miner Res 2001 Jan;16(1):141-7

134.Kannel WB Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens 2000 Feb;14(2):83-90

135.Kansanen M, Vanninen E, Tuunainen A, Pesonen P, Tuononen V, Hartikainen J, Mussalo H, Uusitupa M The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998 Jul;18(4):377-85

136.Karklin A., Driver H. S., Buffensnein R. Restricted energy intake affekts nocturnal body temperature and sleep patterns. Am. J. Clin. Nutr. 1994 59 346-349.

137.Katan MB Effect of low-fat diets on plasma high-density lipoprotein concentrations Am J Clin Nutr 1998;67:573S-576S.

138.Katzel LI; Bleecker ER; Colman EG; Rogus EM; Sorkin JD; Goldberg AP Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA 1995 Dec 27;274(24):1915-21

139.Kieffer TJ; Heller RS; Habener JF Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun 1996 Jul 16;224(2):522-7

140.King BM; Arceneaux ER; Cook JT; Benjamin AL.,; Alheid GF Temporal lobe lesion-induced obesity in rats: an anatomical investigation of the posterior amygdala and hippocampal formation. Physiol Behav 1996 Apr-May;59(4-5):843-8

175

141.Kirschner M. A. et al., An eight-year experience with a very-low-calorie formula diet for control of major obesity. Int. J. Obes. 1988. vol 12. - p. 69-80.,

142.Klein S; Coppack SW; Mohamed-Ali V; Landt M Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996 Jul;45(7):984-7

143.Kopelman P, Formiguera X Obesity and type 2 diabetes. Int J Obes Relat Metab Disord 1999 Jun;23 Suppl 7:S1

144.Kortelainen ML., Sarkioja T .Coronary atherosclerosis associated with body structure and obesity in 599 women aged between 15 and 50 years// Int J Obes Relat Metab Disord .-1999, №Aug;23(8).-P.838-882.

145.Kraegen EW, Cooney GJ, Ye J, Thompson AL. Triglycerides, fatty acids and insulin resistance – hyperinsulinemia// Exp Clin Endocrinol Diabetes.- 2001, 1109(4).-Р.516-526.

146.Kriketos A. D., Lillioja S., Pan D. A. et al., Interrelationships between muscle metabolism and obesity in adult pima indians.// Int. J. Obes. 1995. - V.19. - P. 211.

147.Kuczmarski R. J. Prevalence of overweight and weight gain in the United States. Am. J. Clin. Nutr. 1992 55 (Suppl) : 495S-502S.

148.Kunath U; Memari B Laparoskopisches "Gastric Banding" zur Behandlung der pathologischen Adipositas. Chirurg 1995 Dec;66(12):1263-7

149.Lallement M; Chiotasso P; Falewee MN; Abbes M Reflexions sur la place de la coelio-chirurgie chez les obeses majeurs. J Chir (Paris) 1995 Oct;132(10):386-

150.Lauterio TJ, Davies MJ, DeAngelo M, Peyser M, Lee J Neuropeptide Y expression and endogenous leptin concentrations in a dietary model of obesity. Obes Res 1999 Sep;7(5):498-505

151.Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant// Sleep.- 2001.V. Sep 15, №24(6).-Р.721-5.

152.Lawton C. L., Wales J. K., Blundell J. E. Dietary fat and appetite control in obese female subjects. Int. J. Obes. 1994. - V.18. - P.838.

153.Lean M. E. J Clinical handbook of weight management. Martin Dunitz 1998, P. 113.

154.Lee L., Kumar S., Leong L. C. The impact of five-month basic military training on the body weight and body fat of 197 moderately to severely obese Singaporean aged 17 to 19 years. Int J Obes Relat Metab Disord 1994 18 105-109.

155.Leibowitz SF, Alexander JT Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 1998 Nov 1;44(9):851-64

156.Yip I, Go VL, Hershman JM et al. Leptin-Visceral fat relation during weight loss// Pancreas.- 2001.-V. Aug23, №2.-Р197-203.

157.Leung SS; Ng MY; Lau TF (Prevalence of obesity in Hong Kong children and adolescents aged 3-18 years) Chung Hua Yu Fang I Hsueh Tsa Chih 1995 Sep;29(5):270-2

176

158.Lichtenstein AH, Kennedy E, Barrier P, et al Dietary fat consumption and health. Nutr Rev 1998 May;56(5 Pt 2):S3-19; discussion S19-28

159.Lichtenstein AH.; Kennedy E.; Barrier P., et al. Dietary fat consumption and health // Nutr Rev.-1998 , №ay;56(5 Pt 2).- Р.3-19.- discussion S.19-28.

160.Lissner L, Heitmann BL Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr 1995 Feb;49(2):79-90

161.Lissner L, Heitmann BL, Bengtsson C Low-fat diets may prevent weight gain in sedentary women: prospective observations from the population study of women in Gothenburg, Sweden. Obes Res 1997 Jan;5(1):43-8

162.Liu J, Askari H, Dagogo-Jack S Reproducibility of fasting plasma leptin concentration in lean and obese humans. Endocr Res 1999 Feb;25(1):1-10

163.Macdiarmid JI, Vail A, Cade JE, Blundell JE The sugar-fat relationship revisited: differences in consumption between men and women of varying BMI. Int J Obes Relat Metab Disord 1998 Nov;22(11):1053-61

164.Mamalakis G; Kafatos A Prevalence of obesity in Greece. - Int J Obes Relat Metab Disord 1996 May;20(5):488-92 -

165.Marckmann P, Astrup A Fatty diets are unhealthy-even those based on monounsaturates. Am J Clin Nutr 2000 Sep;72(3):853-6

166.McGregor GP; Desaga JF; Ehlenz K; Fischer A; Heese F; Hegele A; Lammer C; Peiser C; Lang RE Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 1996 Apr;137(4):1501-4

167.McGuire MT, Wing RR, Klem ML, Lang W, Hill JO What predicts weight regain in a group of successful weight losers? J Consult Clin Psychol 1999 Apr;67(2):177-85

168.Meigs JB; Jacques PF; Selhub J; Singer DE. et al Meigs JB; Jacques PF; Selhub J; Singer DE. et al Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study // Diabetes Care.- 2001, №Aug;24(8).-Р.1403-10.

169.Melia AT; Mulligan TE; Zhi J Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers. J Clin Pharmacol 1996 Apr;36(4):352-5.

170.Mikhail N, Golub MS, Tuck ML Obesity and hypertension. Prog Cardiovasc Dis 1999 Jul-Aug;42(1):39-58

171.Mikhail N.; Golub MS.; Tuck ML. Obesity and hypertension// Prog Cardiovasc Dis .-1999 , № Jul-Aug;42(1).-P.39-58.

172.Mikkelsen PB, Toubro S, Astrup A Effect of fat-reduced diets on 24-h energy expenditure: comparisons between animal protein, vegetable protein, and carbohydrate. Am J Clin Nutr 2000 Nov;72(5):1135-41

173.Mikkelsen PB, Toubro S, Astrup A Effect of fat-reduced diets on 24-h energy expenditure: comparisons between animal protein, vegetable protein, and carbohydrate. Am J Clin Nutr 2000 Nov;72(5):1135-41

177

174.Muller DC; Elahi D; Tobin JD; Andres R. The effect of age on insulin resistance and secretion: a review. // Semin Nephrol.- 1996, № Jul;16(4).-Р. 289-298.

175.Nolan JJ; Olefsky JM; Nyce MR; Considine RV; Caro JF Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes 1996 Sep;45(9):1276-8

176.Orbach P, Lowenthal DT Evaluation and treatment of hypertension in active individuals. Med Sci Sports Exerc 1998 Oct;30(10 Suppl):S354-66

177.Oster G, Thompson D, Edelsberg J, Bird AP, Colditz GA Lifetime health and economic benefits of weight loss among obese persons. Am J Public Health 1999 Oct;89(10):1536-42

178.Pekkarinen T; Takala I; Mustajoki P Two year maintenance of weight loss after a VLCD and behavioural therapy for obesity: correlation to the scores of questionnaires measuring eating behaviour. Int J Obes Relat Metab Disord 1996 Apr;20(4):332-7

179.Pietinen P; Vartiainen E; Mannisto S Trends in body mass index and obesity among adults in Finland from 1972 to 1992. Int J Obes Relat Metab Disord 1996 Feb;20(2):114-20

180.Pi-Sunyer F. X. Effects of the composition of the diet on energy intake. Nutr. Rev. 1990. Vol. 48. - P. 94-105

181.Prentice AM; Jebb SA Obesity in Britain: gluttony or sloth? BMJ 1995 Aug 12;311(7002):437-9

182.Pugeat M, Ducluzeau PH Insulin resistance, polycystic ovary syndrome and metformin. Drugs 1999;58 Suppl 1:41-6; discussion 75-82

183.Purnell JQ, Brunzell JD.The central role of dietary fat, not carbohydrate, in the insulin resistance syndrome// Curr Opin Lipidol.- 1997, № Feb;8(1).-Р.17-22.

184.Rauh-Pfeiffer A, Kelleher D, Duggan C Obesity and low-fat diets in pediatrics. Curr Opin Pediatr 1998 Jun;10(3):329-35

185.Reaven GM. Diet and Syndrome X// Curr Atheroscler Rep.- 2000 Nov;2(6):Р.503-507.

186.Reaven GM. Pathophysiology of insulin resistance in human disease// Physiol Rev.- 1995.- V.Jul.75, №3.-Р.473-486.

187.Riccardi G, Rivellese AA. Dietary treatment of the metabolic syndrome--the optimal diet; Review // Br J Nutr.- 2000, № Mar;83.-Р.143-S148.

188.Roberts L, Haycox A Obesity. About the size of it. Health Serv J 1999 Jul 8;109(5662):28-9

189.Rogers PJ Eating habits and appetite control: a psychobiological perspective. Proc Nutr Soc 1999 Feb;58(1):59-67

190.Ryan DH; Kaiser P; Bray GA Sibutramine: a novel new agent for obesity treatment. Obes Res 1995 Nov;3 Suppl 4:553S-559S

191.Ryttig KR; Rossner S Weight maintenance after a very low calorie diet (VLCD) weight reduction period and the effects of VLCD supplementation. A

178

prospective, randomized, comparative, controlled long-term trial. J Intern Med 1995 Oct;238(4):299-306

192.Salas-Salvado J., Barenys-Manent M. A., Recasens G. et al., Influence of adiposity on thermic effect of food and exercise in lean and obese adolescents. Int. J. Obes 1993 17 717-722.

193.Samaras K, Kelly PJ, Campbell LV Dietary underreporting is prevalent in middle-aged British women and is not related to adiposity (percentage body fat). Int J Obes Relat Metab Disord 1999 Aug;23(8):881-8

194.Saris WH Exercise with or without dietary restriction and obesity treatment. Int J Obes Relat Metab Disord 1995 Oct;19 Suppl 4:S113-6

195.Saris WH Fit, fat and fat free: the metabolic aspects of weight control. Int J Obes Relat Metab Disord 1998 Aug;22 Suppl 2:S15-21

196.Saris WH, Astrup A, Prentice AM, et al. Randomized controlled trial of changes in dietary carbohydrate/fat ratio and simple vs complex carbohydrates on body weight and blood lipids: the CARMEN study. The Carbohydrate Ratio Management in European National diets. Int J Obes Relat Metab Disord 2000 Oct;24(10):1310-8

197.Schlundt D. G., Hill J. O., Pope-Cordle J. et al., Randomized evaluation of a low fat ad libitum carbohydrate diet for weight reduction. Int. J. Obes. 1993. Vol.

17.- P. 623-629

198.Schrauwen P, Lichtenbelt WD, Saris WH, Westerterp KR Fat balance in obese subjects: role of glycogen stores. Am J Physiol 1998 Jun;274(6 Pt 1):E1027-33

199.Schultz C. K., Bernauer P. A., Mole P. A., et al., Effects of severe caloric restriction and moderate exercise on basal metabolic rate and hormonal status in adult humans. Fed. Proc 1980 39 783

200.Schutz Y. Macronutrients and energy balance in obesity. Metabolism 1995 Sep;44(9 Suppl 3):7-11

201.Schutz Y., Tremblay A., Weinsier R. L., Nelson K. M. Role of fat oxidation in the long term stabilization of body weight in obese women. Am. J. Clin. Nutr. 1992. - V.55. - P. 670-674.

202.Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D Jr; Woods SC; Seeley RJ; Weigle DS Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996 Apr;45(4):531-5

203.Schwartz MW; Peskind E; Raskind M; Boyko EJ; Porte D Jr Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996 May;2(5):589-93

204.Segal K.R. Gutin B. Thermic effects of food and exercise in lean and obesity women. Metabolism 1983 32 581-589.

205.Segal KR; Landt M; Klein S Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996 Jul;45(7):988-

179

206.Seidell J. C. Dietary fat and obesity: an epidemiologic perspective Am J Clin Nutr 1998;67:546S-550S.

207.Seidell J. C., Flegal K. M. Assessing obesity: classification and epidemiology. Br Med Bull 1997 53 238-252

208.Seidell JC Obesity in Europe. Obes Res 1995 Sep;3 Suppl 2:89s-93s

209.Seim HC; Mitchell JE; Pomeroy C; de Zwaan M Electrocardiographic findings associated with very low calorie dieting. Int J Obes Relat Metab Disord 1995 Nov;19(11):817-9

210.Sichieri R; Recine E; Everhart JE Growth and body mass index of Brazilians ages 9 through 17 years. Obes Res 1995 Sep;3 Suppl 2:117s-121s

211.Silverstone T. Appetite suppressants. /Drugs. 1992 43. 6. 820-836

212.Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998 Jul 18;352(9123):167-72

213.Skov AR, Toubro S, Ronn B, Holm L, Astrup A Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord 1999 May;23(5):528-36

214.Spieth LE, Harnish JD, Lenders CM, Raezer LB, Pereira MA, Hangen SJ, Ludwig DS A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med 2000 Sep;154(9):947-51

215.Steinmetz A, Fenselau S, Schrezenmeir J.Treatment of dyslipoproteinemia in the metabolic syndrome// Exp Clin Endocrinol Diabetes.- 2001.- V.109, №4.- Р.548-559.

216.Stern JS; Hirsch J; Blair SN; Foreyt JP; Frank A; Kumanyika SK; Madans JH; Marlatt GA; St Jeor ST; Stunkard AJ Weighing the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Obes Res 1995 Nov;3(6):591-604

217.Stern M Epidemiology of obesity and its link to heart disease. Metabolism 1995 Sep;44(9 Suppl 3):1-3

218.Straznicky NE, O'Callaghan CJ, Barrington VE, Louis WJ Hypotensive effect of low-fat, high-carbohydrate diet can Be independent of changes in plasma insulin concentrations. Hypertension 1999 Oct;34(4 Pt 1):580-5

219.Sugerman HJ; Felton WL 3rd; Salvant JB Jr; Sismanis A; Kellum JM Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 1995 Sep;45(9):1655-9

220.Tremblay A. Human obesity: a defect of lipid oxidation or in thermogenesis? Int. J. Obes. 1992. - V.16. - P. 953-957.

221.Valtuena S; Blanch S; Barenys M; Sola R; Salas-Salvado J Changes in body composition and resting energy expenditure after rapid weight loss: is there an en-

180

ergy-metabolism adaptation in obese patients? Int J Obes Relat Metab Disord 1995 Feb;19(2):119-25

222.van Baak MA Exercise training and substrate utilisation in obesity. Int J Obes Relat Metab Disord 1999 Apr;23 Suppl 3:S11-7

223.Vander Tuig JG, Beneke WM Low-protein diet blocks development of hyper-

phagia and obesity in rats with hypothalamic knife cuts. J Nutr 1996 Jun;126(6):1713-21

224.Wannamathee G., Shaper A. G. Weight change in middle-aged British men: implications for health. Eur. J. Clin. Nutr. 1989 44 133-142

225.Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT Prevalence of valvularregurgitation associated with dexfenfluramine three to five months after discontinuation of treatment. J Am Coll Cardiol 1999 Dec;34(7):2088-95

226.Wells JC Is obesity really due to high energy intake or low energy expenditure? Int J Obes Relat Metab Disord 1998 Nov;22(11):1139-40

227.Weyer C, Snitker S, Rising R, Bogardus C, Ravussin E Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat Metab Disord 1999 Jul;23(7):715-22

228.Weyer C.; Snitker S.; Rising R.; Bogardus C. еt al Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects // Int J Obes Relat Metab Disord .- 1999, № Jul;23(7).-P.715-737.

229.Willett WC Is dietary fat a major determinant of body fat? Am J Clin Nutr 1998;67:556S-562S.

230.Williams KV, Mullen ML, Kelley DE, Wing RR The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care 1998 Jan;21(1):2-8

231.Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr 2001;21:323-41

232.Wing RR. Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1995 May;95(5):56972; quiz 573-4

233.Wong J, Reddy SS, Klein AL Anorectic drugs and valvular heart disease: a biological and clinical perspective. Cleve Clin J Med 1998 Jan;65(1):35-41

234.Wurtman J, Wurtman R, Reynolds S et al., D-fenfluramine supresses snack intake among carbohydrate cravers but not among non-carbohydrate cravers. Inter. J. Eat. Disord.- 1987. - V.6.,N8. - P. 687-699.

235.Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S; Ozawa N; Suzuki Y; Maeno H; Kato K; et al., Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body

weight but also to improve insulin sensitivity.	Diabetes Care	1995
Jun;18(6):775-8

181

236.Yki-Jarvinen H, Nikkila K, Makimattila S Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Drugs 1999;58 Suppl 1:53-4; discussion 75-82

237.Zanella MT, Kohlmann O Jr, Ribeiro AB. Treatment of obesity hypertension and diabetes syndrome// Hypertension.- 2001.- V. Sep.38, № (3 Pt 2).-Р.705-8.

238.Zhi J., Melia A. T., Guerciolini R., et al., Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol. Ther. 1994 56 82-85).

239.Zhi J; Melia AT; Eggers H; Joly R; Patel IH Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. J Clin Pharmacol 1995 Nov;35(11):1103-8).

240.Ziegler O.; Quilliot D.; Guerci B.; Drouin P. Macronutrients, fat mass, fatty acid flux and insulin sensitivity// Diabetes Metab.- 2001.- V. Apr;27, №(2 Pt 2).- Р.261-270.

241.Zimmet P, Collier G Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg. Drugs 1999;58 Suppl 1:21-8; discussion 75-82

242.Zoppi G; Luciano A; Vinco A; Residori P L'obesita in Pediatria: analisi statistica del rendimento scolastico dei bambini obesi. Pediatr Med Chir 1995 Nov-Dec;17(6):559-61